A diversified Indian company, ITC Limited, confirmed on November 25, 2021, that it has begun clinical trials of a nasal spray that can prevent COVID-19 infection.
The Asian Development Bank (ADB) has approved a $1.5 billion loan (approx Rs 11,185 crore) to help the Government of India purchase safe and effective vaccines against the coronavirus (COVID-19).